Drug intelligence / Profile preview

BromSite

Development stage
Approved
Lead developer
Sun Pharma
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

BromSite (ISV-303) is a topical ophthalmic solution containing 0.075% bromfenac, a non-steroidal anti-inflammatory drug (NSAID), formulated with the DuraSite drug delivery technology. Developed by InSite Vision (a subsidiary of Sun Pharmaceutical Industries), it is the first NSAID approved by the FDA for both the treatment of postoperative inflammation and the prevention of ocular pain in patients undergoing cataract surgery. The DuraSite platform is a synthetic polymer-based system that increases the residence time of the drug on the ocular surface, allowing for lower dosing concentrations compared to conventional formulations. Bromfenac works by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, thereby blocking the synthesis of prostaglandins involved in inflammation and pain.

Brand names
BromSite
Other names
bromfenac ophthalmic solution 0.075%
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on BromSite.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BromSite.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call